Detroit Personal Injury Lawyers Fighting For The Injured

Zantac Facts

The popular heartburn medication, Zantac, has recently been recalled by the U.S. Food and Drug Administration (FDA). The drug’s active ingredient, ranitidine, has been found by Valisure online analytical pharmacy to inherently contain the cancer-causing element, N-nitrosodimethylamine (NDMA).

When The Issue Began

The Zantac recall was issued by the FDA on September 13, 2019, once the agency became aware of the cancer-causing impurity within the drug.

At this time, the FDA has issued a statement alleging that “NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.”

However, according to David Light, CEO of Valisure, “There’s no acceptable cancer risk for a drug like this.”

A Problematic Drug

Since Zantac is an over-the-counter (OTC) drug, millions of Americans are exposed to its cancer-causing impurities on a regular basis. Until now, people had no logical reason to question the purity of the drug’s ingredients.

While NDMA is not known to the FDA to cause cancer in small doses, it is reasonable to assume that many people take the drug for heartburn relief regularly, if not daily. That means a significant number of people have been exposed to the cancer-causing impurity for an extended period of time, which means those people have the potential risk of NDMA accumulation within their bodies.

As stated by the FDA, “NDMA is classified as a probable human carcinogen” and “People taking OTC ranitidine could consider using other OTC medicines approved for their condition.”

If you have taken Zantac regularly for heartburn relief, you may be entitled to compensation. The skilled attorneys at Goodman Acker are highly experienced in product liability law and have helped many others just like you. Don’t hesitate; contact our firm with your case right away.

Call Goodman Acker today at (248) 793-2010 if you’ve been taking Zantac or other ranitidine medications for heartburn relief.